<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03387059</url>
  </required_header>
  <id_info>
    <org_study_id>MS700623-0009</org_study_id>
    <nct_id>NCT03387059</nct_id>
  </id_info>
  <brief_title>Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice Forielle</brief_title>
  <acronym>ENDOMEDE</acronym>
  <official_title>A Multicentre, Prospective Randomised Controlled, Interventional Clinical Investigation to Assess the Clinical Safety and Performance of Forielle, a Medical Device for Endometrial Washing in Restoring Favorable Endometrial Condition to Implantation After COS During Assisted Reproductive Practice (ENDOMEDE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck KGaA, Darmstadt, Germany</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Serono S.P.A., Italy</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Merck KGaA, Darmstadt, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, prospective randomized controlled, interventional investigation to
      assess the safety and clinical performance of Forielle, a medical device for endometrial
      washing, in restoring favorable endometrial condition to implantation after Controlled
      Ovarian Stimulation (COS) during Assisted Reproductive Technique (ART).
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study was terminated early, due to the poor feasibility and sustainability, leading to slow
    recruitment rate.
  </why_stopped>
  <start_date type="Actual">January 12, 2018</start_date>
  <completion_date type="Actual">June 12, 2018</completion_date>
  <primary_completion_date type="Actual">June 12, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implantation Rate</measure>
    <time_frame>Post Embryo Transfer (PET) Days 21 to 28</time_frame>
    <description>Implantation rate was defined as the number of intrauterine gestational sacs divided by the number of embryos transferred.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Positive and Negative Pregnancy</measure>
    <time_frame>At Post Embryo Transfer (PET) Day 14</time_frame>
    <description>Positive and Negative Pregnancy measured by Day 14 serum beta Human chorionic gonadotropin (Beta-HCG) pregnancy test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Confirmed Ongoing Pregnancy</measure>
    <time_frame>Post Embryo Transfer (PET) Days 70 to 84</time_frame>
    <description>Ongoing pregnancy was defined as having a positive fetal heart beat (FHB) as assessed by obstetric ultrasound (transvaginal or abdominal).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Device Incidents</measure>
    <time_frame>Day 2 post-randomization (PR) up to Post Embryo Transfer (PET) Days 70 to 84</time_frame>
    <description>A medical device incident is any malfunction or deterioration in the characteristics and/or clinical performance of a device, as well as any inadequacy in the labelling or the instructions for use (IFU) which, directly or indirectly, might lead to or might have led to the death of a participant, or user or of other persons or to a serious deterioration in their state of health.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Forielle Endometrial Washing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No Endometrial Washing</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Forielle</intervention_name>
    <description>Participants randomized to receive Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomisation).</description>
    <arm_group_label>Forielle Endometrial Washing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All infertile women treated with intracytoplasmic sperm injection (ICSI)/Fertilization
             in Vitro and Embryo Transfer (FIVET)

          -  Less than or equal to (&lt;=) 1 previous failed embryo transfer

          -  Eumenorrheic normo-gonadotropic women

          -  Basal follicle-stimulating hormone (FSH) &lt;=12 International unit per liter (IU/L)

          -  Anti-mullerian hormone (AMH) greater than (&gt;) 1.1 nanogram per milliliter (ng/mL)

          -  Ovarian Reserve: number of antral follicles 2 millimeter (mm) between 6 &lt;= antral
             follicle count (AFC) &lt;= 16

          -  Follicles &gt; 16 mm at the triggering day between 5-14

          -  Body Mass Index (BMI) between 18 &lt;= BMI &lt;= 27 kilogram per meter square (kg/m^2)

          -  Indication for Fresh Embryo transfer

          -  Normal uterine cavity on ultrasound exam (e.g., no presence of hydrosalpinx)

          -  Undergoing Assisted Reproductive Technique (ART) and oocyte maturation by human
             chorionic gonadotropin (HCG) triggering

          -  Progesterone (P4) serum level at the HCG triggering day &lt;= 1.5 ng/mL (Day
             O/Randomization)

          -  Estradiol (E2) &lt;= 3000 picogram/milliliter (pg/mL) at the human chorionic gonadotropin
             (HCG) triggering day (Day 0/Randomization)

          -  Subjects must have read and signed the Informed Consent Form prior to
             study-specific-procedures not part of standard of care

          -  Other protocol defined inclusion criteria could apply

        Exclusion Criteria:

          -  Clinically significant systemic disease (such as diabetes, metabolic syndrome,
             immunological diseases, diagnosed thrombophilia, porphyria, or any other medical
             condition requiring the use of low-molecular weight heparin therapy)

          -  Polycystic ovary syndrome (PCOS) according to Rotterdam Consensus Criteria (European
             Society of Human Reproduction and Embryology [ESHRE]/American Society for Reproductive
             Medicine [ASRM], 2003)

          -  Poor ovarian response (POR) according to the European Society of Human Reproduction
             and Embryology (ESHRE) Criteria

          -  RIF (repeated implantation failure), defined as greater than or equals to (&gt;=) 2
             previous failed embryo transfers

          -  Endometriosis III-IV stage or adenomyosis

          -  Clinically significant findings on exam or ultrasound, such as salpingitis,
             hydrosalpynx or evidence of ovarian cysts

          -  Known hypersensitivity to any of the components of the solution

          -  Known hypersensitivity to vaginal progesterone or its excipients

          -  Other protocol defined exclusion criteria could apply
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>41 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Responsible</last_name>
    <role>Study Director</role>
    <affiliation>Merck KGaA, Darmstadt, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unità Operativa di Fisiopatologia della Riproduzione - Ospedale Cervesi di Cattolica</name>
      <address>
        <city>Cattolica</city>
        <zip>47841</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro di Procreazione Assistita Demetra</name>
      <address>
        <city>Firenze</city>
        <zip>50100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro di Procreazione Medicalmente Assistita - Ospedale di Versilia</name>
      <address>
        <city>Lucca</city>
        <zip>55041</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Humanitas Fertility Center</name>
      <address>
        <city>Milano</city>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Scienze della Natalità - IRCCS Ospedale San Raffaele</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unità Operativa di Ginecologia - Istituti Clinici Zucchi</name>
      <address>
        <city>Monza</city>
        <zip>20052</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro di Procreazione Medicalmente Assistita (PMA) - Casa di Cura PROMEA</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <removed_countries>
    <country>Germany</country>
  </removed_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>December 22, 2017</study_first_submitted>
  <study_first_submitted_qc>December 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2017</study_first_posted>
  <results_first_submitted>June 3, 2019</results_first_submitted>
  <results_first_submitted_qc>August 23, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 24, 2019</results_first_posted>
  <last_update_submitted>August 23, 2019</last_update_submitted>
  <last_update_submitted_qc>August 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infertility</keyword>
  <keyword>Forielle</keyword>
  <keyword>Assisted Reproductive Technique (ART)</keyword>
  <keyword>Controlled Ovarian Stimulation (COS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 9, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/59/NCT03387059/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Nine participants were enrolled and the study was prematurely terminated due to the poor feasibility and sustainability, leading to slow recruitment rate.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Forielle Endometrial Washing</title>
          <description>Participants randomized in this group were assessed using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
        </group>
        <group group_id="P2">
          <title>No Endometrial Washing</title>
          <description>Participants randomized in this group (Control) were assessed without using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Study termination</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The Intent-to-Treat (ITT) population included all randomized participants into the trial.</population>
      <group_list>
        <group group_id="B1">
          <title>Forielle Endometrial Washing</title>
          <description>Participants randomized in this group were assessed using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
        </group>
        <group group_id="B2">
          <title>No Endometrial Washing</title>
          <description>Participants randomized in this group (Control) were assessed without using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="9"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Implantation Rate</title>
        <description>Implantation rate was defined as the number of intrauterine gestational sacs divided by the number of embryos transferred.</description>
        <time_frame>Post Embryo Transfer (PET) Days 21 to 28</time_frame>
        <population>Data was not collected since the study was terminated early due to the poor feasibility and sustainability, leading to slow recruitment rate.</population>
        <group_list>
          <group group_id="O1">
            <title>Forielle Endometrial Washing</title>
            <description>Participants randomized in this group were assessed using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
          </group>
          <group group_id="O2">
            <title>No Endometrial Washing</title>
            <description>Participants randomized in this group (Control) were assessed without using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
          </group>
        </group_list>
        <measure>
          <title>Implantation Rate</title>
          <description>Implantation rate was defined as the number of intrauterine gestational sacs divided by the number of embryos transferred.</description>
          <population>Data was not collected since the study was terminated early due to the poor feasibility and sustainability, leading to slow recruitment rate.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Positive and Negative Pregnancy</title>
        <description>Positive and Negative Pregnancy measured by Day 14 serum beta Human chorionic gonadotropin (Beta-HCG) pregnancy test.</description>
        <time_frame>At Post Embryo Transfer (PET) Day 14</time_frame>
        <population>Data was not collected since the study was terminated early due to the poor feasibility and sustainability, leading to slow recruitment rate.</population>
        <group_list>
          <group group_id="O1">
            <title>Forielle Endometrial Washing</title>
            <description>Participants randomized in this group were assessed using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
          </group>
          <group group_id="O2">
            <title>No Endometrial Washing</title>
            <description>Participants randomized in this group (Control) were assessed without using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Positive and Negative Pregnancy</title>
          <description>Positive and Negative Pregnancy measured by Day 14 serum beta Human chorionic gonadotropin (Beta-HCG) pregnancy test.</description>
          <population>Data was not collected since the study was terminated early due to the poor feasibility and sustainability, leading to slow recruitment rate.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Confirmed Ongoing Pregnancy</title>
        <description>Ongoing pregnancy was defined as having a positive fetal heart beat (FHB) as assessed by obstetric ultrasound (transvaginal or abdominal).</description>
        <time_frame>Post Embryo Transfer (PET) Days 70 to 84</time_frame>
        <population>Data was not collected since the study was terminated early due to the poor feasibility and sustainability, leading to slow recruitment rate.</population>
        <group_list>
          <group group_id="O1">
            <title>Forielle Endometrial Washing</title>
            <description>Participants randomized in this group were assessed using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
          </group>
          <group group_id="O2">
            <title>No Endometrial Washing</title>
            <description>Participants randomized in this group (Control) were assessed without using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Confirmed Ongoing Pregnancy</title>
          <description>Ongoing pregnancy was defined as having a positive fetal heart beat (FHB) as assessed by obstetric ultrasound (transvaginal or abdominal).</description>
          <population>Data was not collected since the study was terminated early due to the poor feasibility and sustainability, leading to slow recruitment rate.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Device Incidents</title>
        <description>A medical device incident is any malfunction or deterioration in the characteristics and/or clinical performance of a device, as well as any inadequacy in the labelling or the instructions for use (IFU) which, directly or indirectly, might lead to or might have led to the death of a participant, or user or of other persons or to a serious deterioration in their state of health.</description>
        <time_frame>Day 2 post-randomization (PR) up to Post Embryo Transfer (PET) Days 70 to 84</time_frame>
        <population>Data was not collected since the study was terminated early due to the poor feasibility and sustainability, leading to slow recruitment rate.</population>
        <group_list>
          <group group_id="O1">
            <title>Forielle Endometrial Washing</title>
            <description>Participants randomized in this group were assessed using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
          </group>
          <group group_id="O2">
            <title>No Endometrial Washing</title>
            <description>Participants randomized in this group (Control) were assessed without using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Device Incidents</title>
          <description>A medical device incident is any malfunction or deterioration in the characteristics and/or clinical performance of a device, as well as any inadequacy in the labelling or the instructions for use (IFU) which, directly or indirectly, might lead to or might have led to the death of a participant, or user or of other persons or to a serious deterioration in their state of health.</description>
          <population>Data was not collected since the study was terminated early due to the poor feasibility and sustainability, leading to slow recruitment rate.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Baseline up to Day 152</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Forielle Endometrial Washing</title>
          <description>Participants randomized in this group were assessed using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
        </group>
        <group group_id="E2">
          <title>No Endometrial Washing</title>
          <description>Participants randomized in this group (Control) were assessed without using Forielle endometrial washing (an intrauterine solution) following oocyte retrieval on Study Day 0 (Randomization).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <limitations_and_caveats>The study was terminated early, due to the poor feasibility and sustainability, leading to slow recruitment rate.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Communication Center</name_or_title>
      <organization>Merck KGaA, Darmstadt, Germany</organization>
      <phone>+49-6151-72-5200</phone>
      <email>service@emdgroup.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

